Freddy Galvis gets 50-game PED suspension

36 Comments

Apparently, he’s the new Manny Alexander.

Injured Phillies infielder Freddy Galvis was suspended 50 games Tuesday after testing positive for Clostebol, a performance-enhancing substance.

In a statement, Galvis claimed that “a trace amount of a banned substances — 80 parts in a trillion — was detected in my urine sample” and that he’d never knowingly take a banned substance. He apologized to “all of my fans, especially here in Philadelphia and back home in Venezuela, to my teammates and to the Phillies organization.”

Taking over as the Phillies’ starting second baseman with Chase Utley out, Galvis was hitting .226/.254/.363 with three homers and 24 RBI in 190 at-bats when he suffered a back injury earlier this month. The injury was later diagnosed as a fractured vertebra and was expected to sideline Galvis for at least another month, if not for most of the rest of the season.

Galvis will be able to serve his suspension while on the disabled list, so it might not actually cost him any additional time. It will cost him about $150,000 in salary, though.

While Galvis’ offensive production was modest, it was still a somewhat pleasant surprise given his history. He had 19 extra-base hits in 190 at-bats for the Phillies, an average of one every 10 at-bats. In his four minor league seasons, he averaged one extra-base hit every 19.6 at-bats. His 15 doubles led the Phillies at the time of his injury.

Update: The Phillies have released a statement:

The Phillies continue to believe in and endorse Major League Baseball’s drug policy. We also support Freddy Galvis in his determination to put this matter behind him and we look forward to his return as a productive member of the Phillies as soon as possible.

After the suspension was announced, Galvis tweeted, in Spanish, about turning the page:

Report: Brewers sign Yovani Gallardo to a major league deal

Getty Images
12 Comments

Free agent right-hander Yovani Gallardo is headed back to the Brewers on a major league deal, The Athletic’s Ken Rosenthal reports. No other terms have been reported yet, as the agreement is still pending a physical.

Gallardo, 31, completed a one-year run with the Mariners before getting his $13 million option declined by the team last month. He provided little value during his time in Seattle, pitching to a 5-10 record in 22 starts and putting up a 5.72 ERA, 4.1 BB/9 and 6.5 SO/9 in 130 2/3 innings as both a starter and reliever.

Still, assuming the veteran righty is on the cusp of a comeback, he may as well try for it with his original club. Gallardo last appeared for the Brewers from 2007 to 2014, racking up a cumulative 20.8 fWAR and peaking during the 2010 season, when he earned his first All-Star nomination and Silver Slugger award. This will be his ninth career season with the club.

Even with Gallardo aboard, the Brewers are expected to continue deepening their pitching stores for 2018. With team ace Jimmy Nelson still recovering from shoulder surgery, the club will enter the season with a projected rotation of Gallardo, Zach Davies, Chase Anderson and Junior Guerra, the latter of whom pitched just 70 1/3 innings in 2017 following a right calf strain and shin contusion. Another big name pitcher could help cement Milwaukee’s rotation and keep them competitive for another year, though they don’t appear to have made any concrete moves in that direction so far.